about
Zoonotic helminths affecting the human eyeImplantable miniature telescope (IMT) for vision loss due to end-stage age-related macular degenerationInterventions for age-related visual problems in patients with strokeInterventions for age-related visual problems in patients with stroke+Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of lifeInflammation and its role in age-related macular degenerationImproving function in age-related macular degeneration: a randomized clinical trialLong term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration.[The IOL-Vip system : Principles and clinical application].Knowledge and Use of Low Vision Services Among Persons with Age-related Macular DegenerationA Review of Current and Future Management of Geographic Atrophy.Self-reported quality of life in patients with retinitis pigmentosa and maculopathy of Bothnia typeReliability and validity of abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire: the study of osteoporotic fracturesTracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study.Applying theories and interventions from behavioral medicine to understand and reduce visual field variability in patients with vision loss.Quantitative autofluorescence and cell density maps of the human retinal pigment epithelium.Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials Report No. 5.Genetic basis of inherited macular dystrophies and implications for stem cell therapy.Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic FracturesVisual prosthetic device for bilateral end-stage macular degeneration.Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10.The burden of age-related macular degeneration: a value-based medicine analysisNational Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10Activity of daily living and its associated factors in war survivors with no visual acuity.Longitudinal observation, evaluation and interpretation of coping with mental (emotional) health in low vision rehabilitation using the Dutch ICF Activity InventoryVision loss and psychological distress among Ethiopians adults: a comparative cross-sectional study.How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?Foveal morphology affects self-perceived visual function and treatment response in neovascular age-related macular degeneration: a cohort study.Urgent Eye Care in the UK Increased Demand and Challenges for the Future.Age-Related Macular Degeneration Is Associated with Less Physical Activity among US Adults: Cross-Sectional StudyPerceived quality of health care in macular disease: a survey of members of the Macular Disease Society.Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.Impact of an interdisciplinary low vision service on the quality of life of low vision patients.Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case.Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer.Blindness, low vision, and other handicaps as risk factors attached to institutional residence.Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial.Quality of life in age-related macular degeneration: a review of the literature.Age-related macular degeneration and mortality in older women: the study of osteoporotic fractures
P2860
Q21198919-B4C98884-1846-43A9-9F76-FA7A38C6B3E7Q24194356-EB67AFD6-3D69-402E-8BD0-2E2DF866489EQ24201153-EC68799C-95D9-47D4-B2C1-53E2EF0196F8Q24239939-624B87BF-78F7-4E0B-9F1A-CB236F70F9DAQ24803944-7D7B5DBF-7FAB-4CB9-93BA-07040273E4D7Q26768520-8A4DC1A4-B041-4FA8-8CC2-BF74A7F1AAC5Q30542436-255B66CE-250A-479E-BC03-2963A9121E25Q30739088-168DF5B6-C714-460E-A10E-5422B3BC6F34Q33534730-6FD5C9C7-3103-40B3-B09C-8685ED16D633Q33559860-D1B62CDA-7D1E-4FB0-9F85-C7F4D01C0C2AQ33740158-93D20728-2F14-40F5-80B7-194EB2809215Q33774230-CB3C5557-7463-4DDF-BCAC-9DDD97C9B980Q33821053-0E03021E-B795-4013-8842-951F8141E234Q33892118-9796CE15-F18D-4137-BD30-0C8C81FAD7DEQ33924241-9A15CC56-5389-451A-AAD7-46A3AA6B1349Q34010917-49725041-7AE4-4798-888F-1F043CB2F8CFQ34081879-959A770C-79C5-4252-8189-95DDA4DC8460Q34234455-6631E9BF-F5F7-4391-B4DC-AEDD06A751DCQ34258664-1CAEBFC4-BCD8-48C7-A446-F455574FCE52Q34468393-FD50F4A1-E582-4203-BCAB-C380A8018DC0Q34518507-21B71A77-733D-4005-8EE4-CC95E6288C39Q34534290-41D8F43E-1730-4DCA-B799-43BAC3072AFCQ34565470-93AD2730-35E3-46F6-982C-78D3717A9143Q34655531-5A606D5E-20B7-40E6-8471-F948FD4521B1Q34864107-A940BBCA-B871-4630-A030-BC44972EE533Q35019168-D4CE4182-926C-4773-B15F-54B408B5CDC9Q35036342-C9B64F46-6829-445A-97A1-46F1713D8EA3Q35070975-524AA888-F20F-4FE2-918B-EA41E3ADB9BAQ35117715-5DCB57A7-726A-426B-9A06-4C1291501112Q35155277-063CD8DF-9AE1-42C8-B89A-ABB2ED3DDE88Q35560760-9962E472-8CCA-4658-8771-501160FE0CD9Q35589826-6E18027E-C4E7-4752-89E3-2BBB1ECE9775Q35590440-E495CED8-08DD-40D1-9A15-AB85F417CCE4Q35591508-858EEE61-8B5F-4110-88C5-19138EEB958BQ35592445-D8CB6789-D906-47F0-9101-D3B10122FEA1Q35592449-971A1C5D-6311-4D0D-AEE9-E3571AECACFCQ35592488-5C199A44-9291-4C68-B965-7957A9C550F5Q35592624-CF9218A5-2826-40DA-A1C8-C9FE9F02E175Q35606970-9726B4D3-4281-4571-B8A3-9D14D3184BC4Q35629702-36C40551-B195-4BCE-9794-2088C7FE815D
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
The psychosocial impact of macular degeneration.
@en
The psychosocial impact of macular degeneration.
@nl
type
label
The psychosocial impact of macular degeneration.
@en
The psychosocial impact of macular degeneration.
@nl
prefLabel
The psychosocial impact of macular degeneration.
@en
The psychosocial impact of macular degeneration.
@nl
P2093
P1433
P1476
The psychosocial impact of macular degeneration.
@en
P2093
R A Williams
R G Thomas
R M Kaplan
P304
P356
10.1001/ARCHOPHT.116.4.514
P407
P577
1998-04-01T00:00:00Z